Cargando…
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This prospective cohort study of HCW tested for anti-spike antibodies (LIAISON SARS-CoV-2 S1/S2 IgG assay) at 1, 3, 6, 9, and 12 months after receiving the second BNT162b2 vaccine dose (tests 1, 2, 3, 4,...
Autores principales: | Hussein, Khetam, Dabaja-Younis, Halima, Szwarcwort-Cohen, Moran, Almog, Ronit, Leiba, Ronit, Weissman, Avi, Mekel, Michal, Hyams, Gila, Horowitz, Nethanel A., Gepstein, Vardit, Cohen Saban, Hagar, Tarabeia, Jalal, Halberthal, Michael, Shachor-Meyouhas, Yael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607254/ https://www.ncbi.nlm.nih.gov/pubmed/36298606 http://dx.doi.org/10.3390/vaccines10101741 |
Ejemplares similares
-
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2023) -
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2022) -
COVID-19: Healthcare Workers May Be at Greater Risk Outside Their Work Environment—A Retrospective Observational Study
por: Hussein, Khetam, et al.
Publicado: (2022) -
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort
por: Shachor-Meyouhas, Yael, et al.
Publicado: (2021) -
Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses
por: Braun, Eyal, et al.
Publicado: (2022)